{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:45:43Z","timestamp":1783079143992,"version":"3.54.6"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"publisher","award":["102-2320-B-006-010-MY3"],"award-info":[{"award-number":["102-2320-B-006-010-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"publisher","award":["105-2320-B-006-029-MY3"],"award-info":[{"award-number":["105-2320-B-006-029-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbcan.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T15:30:55Z","timestamp":1491838255000},"page":"199-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer"],"prefix":"10.1016","volume":"1868","author":[{"given":"Yi-Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Rou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien-Hsuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Haw","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2017.04.004_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/181964","article-title":"Clinical significance of ErbB receptor family in urothelial carcinoma of the bladder: a systematic review and meta-analysis","author":"Tsai","year":"2012","journal-title":"Adv. Urol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0015","first-page":"1957","article-title":"Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder","volume":"7","author":"Chow","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0020","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","article-title":"Humanization of an anti-p185HER2 antibody for human cancer therapy","volume":"89","author":"Carter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AJCP61KNVHJVHAFN","article-title":"p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma","volume":"132","author":"Nakazawa","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2009.08.115","article-title":"Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer","volume":"183","author":"Shariat","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0045","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ijc.21852","article-title":"Understanding urothelial carcinoma through cancer pathways","volume":"119","author":"Schulz","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM200011093431915","article-title":"Caspase 3 and p27 as predictors of invasive bladder cancer","volume":"343","author":"Burton","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0055","first-page":"5501","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0060","first-page":"3370","article-title":"Frequent alteration of p63 expression in human primary bladder carcinomas","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jnci\/84.16.1251","article-title":"Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer","volume":"84","author":"Cordon-Cardo","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0070","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.1158\/0008-5472.CAN-05-4627","article-title":"Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients","volume":"66","author":"Tsuruta","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/147323001204000212","article-title":"The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma","volume":"40","author":"Zhang","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/geno.1998.5238","article-title":"Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22","volume":"49","author":"Ben-Porath","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-4800(03)00009-1","article-title":"Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye","volume":"74","author":"Wadehra","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0079-6603(00)64003-5","article-title":"The peripheral myelin protein 22 and epithelial membrane protein family","volume":"64","author":"Jetten","year":"2000","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0095","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1101\/gad.9.15.1846","article-title":"Apoptotic phenotype induced by overexpression of wild-type gas3\/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A","volume":"9","author":"Fabbretti","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0100","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/j.1460-2075.1995.tb07095.x","article-title":"Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth","volume":"14","author":"Zoidl","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0105","first-page":"4363","article-title":"Investigation of prevalence and regulation of expression of progression associated protein (PAP)","volume":"18","author":"Gnirke","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/geno.1997.4524","article-title":"cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family","volume":"41","author":"Chen","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3748\/wjg.v9.i3.392","article-title":"Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA microarray","volume":"9","author":"Wang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0120","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.1158\/0008-5472.CAN-05-1204","article-title":"Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas","volume":"65","author":"Bredel","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-3806(99)00092-9","article-title":"Embryonic expression of epithelial membrane protein 1 in early neurons","volume":"116","author":"Wulf","year":"1999","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0130","first-page":"47","article-title":"Differential expression of the epithelial membrane protein 1 of laryngeal carcinoma","volume":"25","author":"Liu","year":"2003","journal-title":"Zhongguo yi xue ke xue yuan xue bao"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9440(10)62999-9","article-title":"Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis","volume":"167","author":"Johnson","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.mlg.0000161333.67977.93","article-title":"Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways","volume":"115","author":"Kornberg","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0145","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood.V97.12.3890","article-title":"Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity","volume":"97","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-1119(96)00475-1","article-title":"Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins","volume":"183","author":"Ben-Porath","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.advenzreg.2008.04.002","article-title":"Protein kinase CK2\u2014a key suppressor of apoptosis","volume":"48","author":"Ahmad","year":"2008","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1357-2725(99)00050-3","article-title":"Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells","volume":"31","author":"Faust","year":"1999","journal-title":"Int. J. Biochem.Cell Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0165","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.onc.1204411","article-title":"Protein kinase CK2 in mammary gland tumorigenesis","volume":"20","author":"Landesman-Bollag","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0170","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/jnci\/87.21.1630","article-title":"Increased N-myristoyltransferase activity observed in rat and human colonic tumors","volume":"87","author":"Magnuson","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/excr.1997.3679","article-title":"N-myristoyltransferase overexpression in human colorectal adenocarcinomas","volume":"235","author":"Raju","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0180","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<1992::AID-CNCR3>3.0.CO;2-G","article-title":"Increased expression of N-myristoyltransferase in gallbladder carcinomas","volume":"88","author":"Rajala","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11064-004-9680-9","article-title":"Expression of N-myristoyltransferase in human brain tumors","volume":"30","author":"Lu","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0190","first-page":"93","article-title":"Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma","volume":"18","author":"Shrivastav","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JTO.0b013e31816bce65","article-title":"Tumor suppressor FUS1 signaling pathway","volume":"3","author":"Ji","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI116200","article-title":"Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer","volume":"91","author":"Talamonti","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/978-94-007-2888-2_28","article-title":"The biology of protein kinase C","volume":"740","author":"Zeng","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/318472a0","article-title":"Specific growth response of ras-transformed embryo fibroblasts to tumour promoters","volume":"318","author":"Dotto","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0215","first-page":"5514","article-title":"c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation","volume":"51","author":"Barr","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1074\/jbc.270.1.78","article-title":"Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. Possible molecular mechanisms","volume":"270","author":"Borner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0225","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/carcin\/16.10.2423","article-title":"Altered expression of cyclins and c-fos in R6 cells that overproduce PKC epsilon","volume":"16","author":"Han","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc2110","article-title":"Protein kinase C and other diacylglycerol effectors in cancer","volume":"7","author":"Griner","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0235","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/his.12211","article-title":"Down-regulation of EMP1 is associated with epithelial hyperplasia and metaplasia in nasal polyps","volume":"63","author":"Yu","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0240","doi-asserted-by":"crossref","first-page":"28824","DOI":"10.1074\/jbc.270.48.28824","article-title":"Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family","volume":"270","author":"Taylor","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0245","first-page":"889","article-title":"Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes","volume":"61","author":"Hippo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0250","article-title":"The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0255","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s13277-013-1416-5","article-title":"EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis","volume":"35","author":"Sun","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0260","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3892\/ijo.2014.2488","article-title":"Association of EMP1 with gastric carcinoma invasion, survival and prognosis","volume":"45","author":"Sun","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0265","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.3748\/wjg.v20.i14.4001","article-title":"Epithelial membrane protein 1 negatively regulates cell growth and metastasis in colorectal carcinoma","volume":"20","author":"Sun","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0270","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s13277-013-1441-4","article-title":"EMP1, a member of a new family of antiproliferative genes in breast carcinoma","volume":"35","author":"Sun","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0275","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s13277-013-1456-x","article-title":"EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasion","volume":"35","author":"Sun","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5604\/16652681.1184223","article-title":"Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma","volume":"15","author":"Sawanyawisuth","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0285","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-14-0706","article-title":"Identification of differentially expressed long noncoding RNAs in bladder cancer","volume":"20","author":"Peter","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0290","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/leu.2014.80","article-title":"EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion","volume":"28","author":"Aries","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0295","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ar.21395","article-title":"Epithelial membrane protein 1 inhibits human spinal chondrocyte differentiation","volume":"294","author":"Li","year":"2011","journal-title":"Anat. Rec. (Hoboken)."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0300","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1947603510392022","article-title":"Knockdown epithelial membrane protein 1 suppresses human degenerative intervertebral disc-derived nucleus pulposus cell proliferation","volume":"2","author":"Li","year":"2011","journal-title":"Cartilage"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0305","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/sj.onc.1206349","article-title":"cDNA microarray analysis of genes associated with ERBB2 (HER2\/neu) overexpression in human mammary luminal epithelial cells","volume":"22","author":"Mackay","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/thx.2008.106096","article-title":"Oral steroids enhance epithelial repair in nasal polyposis via upregulation of the AP-1 gene network","volume":"64","author":"Li","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0315","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/humrep\/deh698","article-title":"Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review","volume":"20","author":"Arslan","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0320","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00018-004-4069-0","article-title":"Selection and validation of differentially expressed genes in head and neck cancer","volume":"61","author":"Kuriakose","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003215","article-title":"The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review","volume":"3","author":"Yu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jcp.2010.082404","article-title":"The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis","volume":"64","author":"Zhang","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5507\/bp.2007.010","article-title":"Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas","volume":"151","author":"Turashvili","year":"2007","journal-title":"Biomed. Pap. Med. Leukemia Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0340","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1073\/pnas.0502113102","article-title":"Epithelial membrane protein-1 is a biomarker of gefitinib resistance","volume":"102","author":"Jain","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0345","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-1119(96)00134-5","article-title":"Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family","volume":"175","author":"Taylor","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0350","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1091\/mbc.E03-07-0488","article-title":"The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins","volume":"15","author":"Wadehra","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1521-6616(03)00048-2","article-title":"The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death","volume":"107","author":"Wadehra","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0360","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1167\/iovs.07-1598","article-title":"FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction","volume":"50","author":"Morales","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0365","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/02713683.2011.561468","article-title":"Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR)","volume":"36","author":"Telander","year":"2011","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019945","article-title":"Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src","volume":"6","author":"Fu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0375","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1002\/cncr.25259","article-title":"Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development","volume":"116","author":"Habeeb","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0380","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-10-0368","article-title":"Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer","volume":"16","author":"Fu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-7827-6-15","article-title":"Steroid hormone regulation of EMP2 expression and localization in the endometrium","volume":"6","author":"Wadehra","year":"2008","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0390","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1158\/1535-7163.MCT-13-0199","article-title":"Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer","volume":"13","author":"Fu","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0395","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajpath.2013.05.015","article-title":"Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract","volume":"183","author":"Wang","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0400","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.18632\/oncotarget.3312","article-title":"The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-000900","article-title":"Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study","volume":"2","author":"Chen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0410","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7314\/APJCP.2015.16.2.653","article-title":"Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications","volume":"16","author":"Ahmed","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0415","doi-asserted-by":"crossref","first-page":"13974","DOI":"10.1074\/jbc.M113.543728","article-title":"Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma","volume":"289","author":"Qin","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0420","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1167\/iovs.08-3315","article-title":"Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2)","volume":"50","author":"Morales","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0425","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncr.21957","article-title":"Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome","volume":"107","author":"Wadehra","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0430","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ydbio.2006.01.015","article-title":"Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse","volume":"292","author":"Wadehra","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0435","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1167\/iovs.10-6139","article-title":"Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web","volume":"52","author":"Morales","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0440","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1167\/iovs.12-11013","article-title":"Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells","volume":"54","author":"Morales","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0445","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1038\/onc.2012.622","article-title":"EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF","volume":"32","author":"Gordon","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0450","series-title":"Molecular Imaging and Contrast Agent Database (MICAD), Bethesda MD","article-title":"64Cu-labeled DOTA conjugated anti-epithelial membrane protein 2 minibody KS83","author":"Chopra","year":"2004"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0455","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1158\/1078-0432.CCR-08-1016","article-title":"Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines","volume":"14","author":"Shimazaki","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11307-012-0558-y","article-title":"Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments","volume":"15","author":"Fu","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0465","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2407-10-666","article-title":"Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients","volume":"10","author":"Obermayr","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0470","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2012.06.002","article-title":"Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells","volume":"102","author":"Morales","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0475","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/0008-5472.CAN-04-4283","article-title":"EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma","volume":"65","author":"Alaminos","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0480","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1750-3639.2007.00083.x","article-title":"DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in human gliomas","volume":"17","author":"Kunitz","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0485","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14728220902988549","article-title":"EMP3 as a candidate tumor suppressor gene for solid tumors","volume":"13","author":"Fumoto","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yexmp.2013.07.001","article-title":"Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer","volume":"95","author":"Xue","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0495","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2008.08.021","article-title":"EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma","volume":"274","author":"Fumoto","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0500","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2013.12.001","article-title":"Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway","volume":"192","author":"Wang","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0505","doi-asserted-by":"crossref","first-page":"34859","DOI":"10.18632\/oncotarget.5414","article-title":"Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K\/Akt pathway","volume":"6","author":"Hsieh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0510","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.3892\/mmr.2015.4326","article-title":"Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma","volume":"12","author":"Hong","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0515","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000074429","article-title":"Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling","volume":"24","author":"Evtimova","year":"2003","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0520","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjc.6693404","article-title":"Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis","volume":"81","author":"Scorilas","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0525","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1677\/ERC-08-0072","article-title":"Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma","volume":"15","author":"Margetts","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0530","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1158\/1078-0432.CCR-09-0695","article-title":"Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival","volume":"15","author":"Ernst","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0535","first-page":"300","article-title":"The methylation analysis of EMP3 and PCDH-gamma-A11 gene in human glioma","volume":"48","author":"Jiang","year":"2010","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0540","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/neuonc\/noq190","article-title":"DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression","volume":"13","author":"Zheng","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0545","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3892\/or.2012.2047","article-title":"LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation","volume":"28","author":"Pasini","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0550","doi-asserted-by":"crossref","first-page":"756302","DOI":"10.1155\/2013\/756302","article-title":"Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas","volume":"2013","author":"Mellai","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0555","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ijc.22415","article-title":"EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q","volume":"120","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0560","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.ico.0000153556.59407.69","article-title":"Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients","volume":"24","author":"Nielsen","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0565","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bcp.2007.11.006","article-title":"Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells","volume":"75","author":"Su","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0570","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0896-6273(00)80324-4","article-title":"Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis","volume":"18","author":"Burden","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0575","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.juro.2006.07.048","article-title":"Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis","volume":"176","author":"Hsu","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0580","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-12-2440","article-title":"Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-Survivin axis and are sensitive to PI3K inhibitors","volume":"73","author":"Chakrabarty","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0585","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3346\/jkms.2009.24.1.97","article-title":"EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations","volume":"24","author":"Zhou","year":"2009","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0590","doi-asserted-by":"crossref","first-page":"41094","DOI":"10.1074\/jbc.M206868200","article-title":"The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion","volume":"277","author":"Wadehra","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0595","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1083\/jcb.146.2.477","article-title":"Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling","volume":"146","author":"Berditchevski","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0600","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1083\/jcb.146.6.1375","article-title":"Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2)","volume":"146","author":"Sugiura","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0605","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1523-1747.2000.00998.x","article-title":"Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration","volume":"114","author":"Penas","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0610","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BST0390553","article-title":"Tetraspanin CD151 as a target for antibody-based cancer immunotherapy","volume":"39","author":"Haeuw","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0615","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1242\/jcs.114.23.4143","article-title":"Complexes of tetraspanins with integrins: more than meets the eye","volume":"114","author":"Berditchevski","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0620","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/PL00000933","article-title":"Tetraspanins","volume":"58","author":"Boucheix","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0625","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20082422","article-title":"Lateral organization of membrane proteins: tetraspanins spin their web","volume":"420","author":"Charrin","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0630","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1083\/jcb.200108061","article-title":"Specific tetraspanin functions","volume":"155","author":"Hemler","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0635","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00175-7","article-title":"Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration","volume":"37","author":"Mazzocca","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0640","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.177.5.1231","article-title":"Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1\/CD9) DNA","volume":"177","author":"Ikeyama","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0645","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.2910620523","article-title":"Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)","volume":"62","author":"Radford","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0650","first-page":"5284","article-title":"Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0655","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/ijc.22902","article-title":"The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells","volume":"121","author":"Ovalle","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0660","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.1605","article-title":"CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase","volume":"97","author":"Kohno","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0665","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1158\/0008-5472.CAN-06-0391","article-title":"Systemic induction of the angiogenesis switch by the tetraspanin D6.1A\/CO-029","volume":"66","author":"Gesierich","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0670","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1074\/jbc.M008650200","article-title":"Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts","volume":"276","author":"Claas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0675","first-page":"155","article-title":"Membrane rafts as a novel target in cancer therapy","volume":"1845","author":"Hryniewicz-Jankowska","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0680","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ydbio.2005.09.003","article-title":"Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium","volume":"287","author":"Wadehra","year":"2005","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0685","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0690","doi-asserted-by":"crossref","first-page":"29519","DOI":"10.1074\/jbc.M403133200","article-title":"Positive and negative determinants of target gene specificity in myb transcription factors","volume":"279","author":"Lei","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0695","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(02)00906-6","article-title":"A structural mechanism of integrin alpha(IIb)beta(3) \u201cinside-out\u201d activation as regulated by its cytoplasmic face","volume":"110","author":"Vinogradova","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0700","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1242\/jcs.041624","article-title":"Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails","volume":"122","author":"Legate","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0705","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/jcs.018556","article-title":"Linking integrin conformation to function","volume":"122","author":"Askari","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0710","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1242\/jcs.056770","article-title":"Anti-integrin monoclonal antibodies","volume":"122","author":"Byron","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0720","series-title":"The significance of EMP2 and EMP3 genes on human urothelial carcinoma","author":"Yi-Wen","year":"2014"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0725","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0730","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0735","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.matbio.2013.09.002","article-title":"Cross-talk between estradiol receptor and EGFR\/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans","volume":"35","author":"Skandalis","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0740","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000081443","article-title":"Analysis of candidate genes for prostate cancer","volume":"57","author":"Burmester","year":"2004","journal-title":"Hum. Hered."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0745","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11060-008-9579-4","article-title":"Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR","volume":"88","author":"Scrideli","year":"2008","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0750","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1442-2050.2009.01008.x","article-title":"Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development","volume":"23","author":"Zinovyeva","year":"2010","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.bbcan.2017.04.004_bb0755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3892\/ijo.2016.3782","article-title":"The expression and function of epithelial membrane protein 1 in laryngeal carcinoma","volume":"50","author":"Li","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2017.04.004_bb0760","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s11596-012-1043-1","article-title":"EMP-1 promotes tumorigenesis of NSCLC through PI3K\/AKT pathway","volume":"32","author":"Lai","year":"2012","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16301172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16301172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T14:16:40Z","timestamp":1719152200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X16301172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0304419X16301172"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.04.004","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}